These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1220 related articles for article (PubMed ID: 12020339)

  • 1. Diabetes and atherosclerosis: epidemiology, pathophysiology, and management.
    Beckman JA; Creager MA; Libby P
    JAMA; 2002 May; 287(19):2570-81. PubMed ID: 12020339
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Management of coronary artery disease: therapeutic options in patients with diabetes.
    Hammoud T; Tanguay JF; Bourassa MG
    J Am Coll Cardiol; 2000 Aug; 36(2):355-65. PubMed ID: 10933343
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Type 2 diabetes: one disease, multiple cardiovascular risk factors.
    Calles-Escandon J; Garcia-Rubi E; Mirza S; Mortensen A
    Coron Artery Dis; 1999; 10(1):23-30. PubMed ID: 10196684
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Optimal care of patients with type 2 diabetes mellitus and coronary artery disease.
    Frye RL
    Am J Med; 2003 Dec; 115 Suppl 8A():93S-98S. PubMed ID: 14678873
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Atherosclerosis in type 2 diabetes mellitus: the role of insulin resistance.
    Watson KE; Peters Harmel AL; Matson G
    J Cardiovasc Pharmacol Ther; 2003 Dec; 8(4):253-60. PubMed ID: 14740074
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Atherothrombosis in patients with type 2 diabetes mellitus: an overview of pathophysiology].
    Mafrici A; Proietti R
    G Ital Cardiol (Rome); 2010 Jun; 11(6):467-77. PubMed ID: 20922872
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Type 2 diabetes mellitus: a cardiovascular perspective.
    Varughese GI; Tomson J; Lip GY
    Int J Clin Pract; 2005 Jul; 59(7):798-816. PubMed ID: 15963208
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Diabetes mellitus and aging as a risk factor for cerebral vascular disease: epidemiology, pathophysiology and prevention].
    Cantú-Brito C; Mimenza-Alvarado A; Sánchez-Hernández JJ
    Rev Invest Clin; 2010; 62(4):333-42. PubMed ID: 21222313
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association Between Metabolic Syndrome and Microvascular and Macrovascular Disease in Type 2 Diabetic Mellitus.
    Lee MY; Hsiao PJ; Huang JC; Hsu WH; Chen SC; Shin SJ
    Am J Med Sci; 2018 Apr; 355(4):342-349. PubMed ID: 29661347
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Atherosclerosis in type 2 diabetes mellitus and insulin resistance: mechanistic links and therapeutic targets.
    Plutzky J; Viberti G; Haffner S
    J Diabetes Complications; 2002; 16(6):401-15. PubMed ID: 12477625
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Diabetes and peripheral vascular disease.
    Huysman E; Mathieu C
    Acta Chir Belg; 2009 Oct; 109(5):587-94. PubMed ID: 19994800
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Diabetes and the risk of stroke.
    Chukwuma C; Tuomilehto J
    J Diabetes Complications; 1993; 7(4):250-62. PubMed ID: 8219369
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Optimal medical management of peripheral arterial disease.
    Rice TW; Lumsden AB
    Vasc Endovascular Surg; 2006; 40(4):312-27. PubMed ID: 16959725
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Platelet dysfunction in type 2 diabetes.
    Vinik AI; Erbas T; Park TS; Nolan R; Pittenger GL
    Diabetes Care; 2001 Aug; 24(8):1476-85. PubMed ID: 11473089
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Peripheral and cerebrovascular atherosclerotic disease in diabetes mellitus.
    Mukherjee D
    Best Pract Res Clin Endocrinol Metab; 2009 Jun; 23(3):335-45. PubMed ID: 19520307
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Current medical therapies for patients with peripheral arterial disease: a critical review.
    Regensteiner JG; Hiatt WR
    Am J Med; 2002 Jan; 112(1):49-57. PubMed ID: 11812407
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Vascular endothelium as a target of beraprost sodium and fenofibrate for antiatherosclerotic therapy in type 2 diabetes mellitus.
    Otsuki M; Goya K; Kasayama S
    Vasc Health Risk Manag; 2005; 1(3):209-15. PubMed ID: 17319106
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Platelets and Antiplatelet Therapy in Patients with Coronary Artery Disease and Diabetes.
    Neergaard-Petersen S; Hvas AM; Kristensen SD; Grove EL
    Semin Thromb Hemost; 2016 Apr; 42(3):234-41. PubMed ID: 26886397
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Multifactorial aspects of the treatment of the type II diabetic patient.
    Colwell JA
    Metabolism; 1997 Dec; 46(12 Suppl 1):1-4. PubMed ID: 9439550
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The endothelial dysfunction in diabetes mellitus.
    Pănuş C; Moţa M; Vladu D; Vanghelie L; Răducanu CL
    Rom J Intern Med; 2003; 41(1):27-33. PubMed ID: 15529582
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 61.